MMBG Investment Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$261K Sell
9,308
-26,567
-74% -$707K 0.02% 165
2025
Q4
$893K Sell
35,875
-25,260
-41% -$637K 0.08% 104
2025
Q3
$1.56M Sell
61,135
-3,600
-6% -$88.9K 0.14% 86
2025
Q2
$1.57M Sell
64,735
-25,080
-28% -$585K 0.16% 76
2025
Q1
$2.28M Sell
89,815
-1,593
-2% -$41.7K 0.26% 57
2024
Q4
$2.43M Sell
91,408
-2,750
-3% -$74.6K 0.26% 53
2024
Q3
$2.72M Sell
94,158
-23,150
-20% -$675K 0.28% 52
2024
Q2
$3.28M Buy
117,308
+1,173
+1% +$32.3K 0.35% 49
2024
Q1
$3.22M Sell
116,135
-41,720
-26% -$1.16M 0.34% 51
2023
Q4
$4.54M Buy
157,855
+18,730
+13% +$566K 0.53% 40
2023
Q3
$4.61M Buy
139,125
+1,000
+0.7% +$35.4K 0.58% 37
2023
Q2
$5.01M Buy
138,125
+11,180
+9% +$435K 0.61% 38
2023
Q1
$5.18M Sell
126,945
-66,916
-35% -$2.89M 0.66% 36
2022
Q4
$9.93M Hold
193,861
1.32% 21
2022
Q3
$8.48M Hold
193,861
1.14% 23
2022
Q2
$10.2M Sell
193,861
-2,900
-1% -$148K 1.26% 23
2022
Q1
$10.2M Sell
196,761
-14,642
-7% -$760K 1.06% 26
2021
Q4
$12.5M Buy
+211,403
New +$10.5M 1.2% 25

Other funds holding PFE

MMBG Investment Advisors's PFE Position: Q1 2026 in Review

MMBG Investment Advisors reduced its Pfizer (PFE) stake by 74% in Q1 2026, selling an estimated $707K and leaving 9,308 shares worth $261K. The position accounts for 0.02% of the portfolio, ranked #165.

MMBG Investment Advisors first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $12.5M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • MMBG Investment Advisors held 9,308 shares of Pfizer worth $261K as of Q1 2026.
  • MMBG Investment Advisors sold 26,567 Pfizer shares in Q1 2026, an estimated $707K.
  • Pfizer made up 0.02% of MMBG Investment Advisors's portfolio in Q1 2026, its #165 holding.
  • MMBG Investment Advisors first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
  • MMBG Investment Advisors's Pfizer position peaked at $12.5M in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on MMBG Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.